semaglutide pdufa date Retatrutide approval: FDA status, clinical trial results, and when it could be available Upcoming FDA Approvals: New Drugs

6b and Supplementary Fig

Data was retrieved for studies from inception up to 19 April 2022

Clomiphene and cyclofenil are also older SERMs (although perhaps less selective than tamoxifen) (Heuberger and Cohen, 2019)

It is important to acknowledge and begin to plan for more integrated value metrics within this market as the potential population health benefits will require a new lens and integrated value frameworks. She added that since obesity impacts nearly 70% of Americans, understanding the treatment options and economic implications of this market are crucial in the ongoing push towards sustainable patient outcomes.